Legence CFO granted options and RSUs

Legence Corp. Chief Financial Officer Stephen M. Butz received new equity compensation awards.

Rhea-AI Filing Summary

Legence Corp. Chief Financial Officer Stephen M. Butz received new equity compensation awards. He was granted employee stock options covering 18,051 shares of Class A common stock at an exercise price of $50.90 per share, with 18,051 options held directly after the award.

He also received 9,762 restricted stock units, bringing his direct Class A share holdings to 27,619 shares. Both the options and restricted stock units vest in three substantially equal annual installments on the first, second and third anniversaries of the award date, generally requiring continued employment through each vesting date. These are compensation-related grants rather than open-market purchases or sales.

Insider Trade Summary

Grant/Award: 27,813 shares

Grant/Award 2 txns

Insider Butz Stephen M

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Options	18,051	$0.00	$0.00
Grant/Award	Class A Common Stock	9,762	$0.00	$0.00

Holdings After Transaction: Employee Stock Options — 18,051 contracts (Direct); Class A Common Stock — 27,619 shares (Direct)

Footnotes (2)

1. F1. The reported securities represent an award of Restricted Stock Units, which each entitle the reporting person to receive, at vesting, one share of Legence Corp.'s Class A common stock, par value $0.01 per share. The Restricted Stock Units vest in three substantially equal installments on each of the first, second and third anniversaries of the date of the award, subject generally to continued employment through the applicable vesting date.
2. F2. The options will vest in three substantially equal installments on each of the first, second and third anniversaries of the date of the award, subject generally to continued employment through the applicable vesting date. The options expire on the tenth anniversary of the date of the award.

FAQ

What equity awards did Legence Corp. (LGN) CFO Stephen M. Butz receive?

Stephen M. Butz received new equity compensation consisting of stock options and restricted stock units. The grant includes 18,051 employee stock options and 9,762 restricted stock units tied to Legence Corp. Class A common stock, all held directly under standard multi-year vesting terms.

How many stock options were granted to the Legence (LGN) CFO and at what price?

The CFO was granted 18,051 employee stock options with an exercise price of $50.90 per share. These options vest in three substantially equal annual installments and expire on the tenth anniversary of the award date, subject to continued employment through each vesting date.

What are the details of the restricted stock unit grant in this Legence (LGN) Form 4?

The filing shows a grant of 9,762 restricted stock units, each convertible into one share of Class A common stock at vesting. The units vest in three substantially equal installments on the first, second and third anniversaries of the award date, contingent on continued employment.

Did the Legence (LGN) CFO buy or sell shares on the open market in this Form 4?

No open-market buying or selling occurred in this Form 4. All reported transactions are compensation-related awards: stock options and restricted stock units granted at a price of $0.00 per share, subject to multi-year vesting conditions and standard equity compensation terms.

What are Stephen M. Butz’s reported Legence (LGN) holdings after these equity grants?

Following the reported transactions, the CFO directly holds 18,051 employee stock options and 27,619 shares of Class A common stock. These figures reflect the updated positions after the new option and restricted stock unit awards disclosed, under the vesting schedules described in the footnotes.

How do the vesting schedules work for the Legence (LGN) CFO’s new awards?

Both the restricted stock units and the options vest in three substantially equal installments on the first, second and third anniversaries of the award date. Vesting generally requires the CFO to remain employed through each applicable vesting date for the awards to deliver shares or become exercisable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 05:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Butz Stephen M

(Last) (First) (Middle)

C/O LEGENCE CORP.

1601 LAS PLUMAS AVENUE

(Street)

SAN JOSE CALIFORNIA 95133

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Legence Corp. [ LGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	03/16/2026		A		9,762	A	$0	27,619	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options	$50.9	03/16/2026		A		18,051		(2)	(2)	Class A Common Stock	18,051	$0	18,051	D

Explanation of Responses:

1. The reported securities represent an award of Restricted Stock Units, which each entitle the reporting person to receive, at vesting, one share of Legence Corp.'s Class A common stock, par value $0.01 per share. The Restricted Stock Units vest in three substantially equal installments on each of the first, second and third anniversaries of the date of the award, subject generally to continued employment through the applicable vesting date.

2. The options will vest in three substantially equal installments on each of the first, second and third anniversaries of the date of the award, subject generally to continued employment through the applicable vesting date. The options expire on the tenth anniversary of the date of the award.

	/s/ Bryce Seki, as attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)